FMP

FMP

Enter

RMD - ResMed Inc.

photo-url-https://images.financialmodelingprep.com/symbol/RMD.png

ResMed Inc.

RMD

NYSE

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

237.74 USD

3.6 (1.51%)

Historical Prices

From:

To:

234.09235236237237.8209:30 AM09:51 AM10:10 AM10:29 AM10:48 AM11:07 AM11:26 AM11:45 AM12:04 PM12:23 PM12:42 PM01:01 PM01:20 PM01:39 PM01:59 PM02:18 PM02:37 PM02:56 PM03:15 PM03:34 PM03:53 PM

About

ceo

Mr. Michael J. Farrell BE, MBA, SM

sector

Healthcare

industry

Medical - Instruments & Supplies

exchange

NYSE

Description

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based ...

CIK

0000943819

ISIN

US7611521078

CUSIP

761152107

Address

9001 Spectrum Center Boulevard

Phone

858 836 5000

Country

US

Employee

9,980

IPO Date

Jun 2, 1995

Financial Statement

0300M600M900M1.2B1.5B2024 Q32024 Q42025 Q12025 Q22025 Q3RevenueNet Income

Earnings

00.511.522.52023 Q22023 Q32023 Q42024 Q12024 Q22024 Q32024 Q42025 Q1EPS Consensus

RMD Financial Summary

CIK

0000943819

Exchange

NYSE

Industry

Medical - Instrument...

Sector

Healthcare

CUSIP

761152107

ISIN

US7611521078

Country

US

Price

237.74

Beta

0.76

Volume Avg.

1.13M

Market Cap

34.86B

Shares

-

52-Week

179.42-263.05

DCF

255.4

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

26.65

P/B

-

Website

https://www.resmed.com

Upgrades and Downgrades

Rating Distribution

Buy2

Hold0

Sell0

TheFly

6 days ago
Apr 24, 2025

Sector Perform

Sector Perform

TheFly

6 days ago
Apr 24, 2025

Overweight

Overweight

Latest RMD News

Stuart Mooney

8 days ago

ResMed Inc. (NYSE:RMD) Sees Positive Trend in Consensus Pric...

ResMed Inc. (NYSE:RMD) is a prominent player in the healthcare sector, specializing in medical devices and cloud-based software applications. The company focuses on sleep and respiratory care, offering innovative products and services across approximately 140 countries. This extensive market reach and product innovation have contributed to a positive trend in its consensus price target over the past year. The average price target for ResMed has increased from $242.71 a year ago to $265 last mon...

Gordon Thompson

8 days ago

ResMed (NYSE:RMD) Quarterly Earnings Preview

ResMed (NYSE:RMD) is a prominent player in the healthcare sector, specializing in the development and manufacturing of equipment for sleep disorders, such as sleep apnea. The company is set to release its quarterly earnings on April 23, 2025. Analysts predict an earnings per share (EPS) of $2.36 and revenue of approximately $1.28 billion. The anticipated EPS of $2.36 represents a 10.8% increase from the previous year, showcasing ResMed's growth trajectory. This growth is supported by a projecte...

Davit Kirakosyan

Oct 25, 2024

ResMed Shares Climb 8% on Strong Q1 Earnings and Margin Expa...

ResMed (NYSE:RMD) saw its shares rise 8% intra-day today following a robust first-quarter fiscal 2025 report that exceeded Street expectations. The sleep and respiratory care device maker posted adjusted earnings per share of $2.20 for the quarter, above the Street estimate of $2.05. Revenue increased by 11% year-over-year, reaching $1.22 billion and topping projections of $1.19 billion. ResMed’s operational focus contributed to notable margin gains, with gross margin expanding by 420 basis poin...

Tony Dante

Aug 28, 2024

ResMed (NYSE:RMD) Recognized as a Top Growth Stock

ResMed (NYSE:RMD) has caught the attention of investors and analysts alike, being spotlighted by Zacks Investment Research as a top growth stock for those looking to invest for the long term. This recognition is not without merit; ResMed operates within the healthcare sector, focusing on developing, manufacturing, and marketing medical devices and cloud-based software applications that diagnose, treat, and manage respiratory disorders. With a growing demand for healthcare solutions worldwide, Re...

FXEmpire

Aug 9, 2024

ResMed Shares Breathing Life into Big Money Portfolios

Leading respiratory care device maker ResMed Inc. (RMD) is a profit producing machine.

Schwab Network

Aug 8, 2024

ResMed (RMD) CEO on GLP-1 Drugs: "This is a Really Exciting ...

@ResMedAmericas CEO Michael Farrell joins Oliver Renick to talk about the rise of GLP-1 drugs and its impact on the CPAP Therapy. He also discusses A.I.

Zacks Investment Research

Aug 8, 2024

ResMed (RMD) is a Top-Ranked Momentum Stock: Should You Buy?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Investment Research

Aug 2, 2024

ResMed's (RMD) Q4 Earnings Surpass Estimates, Margins Expand

ResMed (RMD) delivers solid performance across all regions and business segments in the fourth quarter of fiscal 2024.

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedin
2017-2025 © Financial Modeling Prep